Submitted by Anonymous (not verified) on 16 January 2026 - 16:00
Human medicines European public assessment report (EPAR): Namuscla, mexiletine hcl, Date of authorisation: 18/12/2018, Revision: 8, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Namuscla, mexiletine hcl, Date of authorisation: 18/12/2018, Revision: 8, Status: Authorised